RS49701B - Vodene suspenzije za nazalnu primenu - Google Patents

Vodene suspenzije za nazalnu primenu

Info

Publication number
RS49701B
RS49701B YUP-361/99A YU36199A RS49701B RS 49701 B RS49701 B RS 49701B YU 36199 A YU36199 A YU 36199A RS 49701 B RS49701 B RS 49701B
Authority
RS
Serbia
Prior art keywords
aqueous suspension
nasal administration
microcrystalline cellulose
application contains
cellulose sodium
Prior art date
Application number
YUP-361/99A
Other languages
English (en)
Inventor
Koji Doi
Original Assignee
Bodor, Nicholas,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bodor, Nicholas, filed Critical Bodor, Nicholas,
Publication of YU36199A publication Critical patent/YU36199A/sh
Publication of RS49701B publication Critical patent/RS49701B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Vodena suspenzija za nazalnu primenu koja obuhvata loteprednol etabonat i mikrokristalnu celulozu natrijum karmeloze.- Prijava sadrži još 3 patentna zahteva.
YUP-361/99A 1997-01-16 1998-01-14 Vodene suspenzije za nazalnu primenu RS49701B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1966497 1997-01-16

Publications (2)

Publication Number Publication Date
YU36199A YU36199A (sh) 2002-09-19
RS49701B true RS49701B (sr) 2007-12-31

Family

ID=12005518

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-361/99A RS49701B (sr) 1997-01-16 1998-01-14 Vodene suspenzije za nazalnu primenu

Country Status (33)

Country Link
US (1) US6368616B1 (sr)
EP (1) EP0973501B1 (sr)
KR (1) KR100471708B1 (sr)
CN (1) CN1126535C (sr)
AR (1) AR011773A1 (sr)
AT (1) ATE249205T1 (sr)
AU (1) AU730953C (sr)
BR (1) BR9806771A (sr)
CA (1) CA2278025C (sr)
CZ (1) CZ294919B6 (sr)
DE (1) DE69818026T2 (sr)
DK (1) DK0973501T3 (sr)
EA (1) EA001775B1 (sr)
ES (1) ES2206880T3 (sr)
HK (1) HK1026138A1 (sr)
HU (1) HU226613B1 (sr)
ID (1) ID21892A (sr)
IL (1) IL130979A0 (sr)
LT (1) LT4677B (sr)
LV (1) LV12449B (sr)
MX (1) MXPA99006628A (sr)
NO (1) NO324619B1 (sr)
NZ (2) NZ509908A (sr)
PL (1) PL190753B1 (sr)
PT (1) PT973501E (sr)
RS (1) RS49701B (sr)
SI (1) SI20057A (sr)
SK (1) SK283164B6 (sr)
TR (1) TR199901663T2 (sr)
TW (1) TW503113B (sr)
UA (1) UA52722C2 (sr)
WO (1) WO1998031343A2 (sr)
ZA (1) ZA98303B (sr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
DE69932144T8 (de) 1998-08-26 2007-10-04 Teijin Ltd. Pulverförmige pernasale mittel
DE19947235A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US6565832B1 (en) * 2000-01-31 2003-05-20 Schering-Plough Healthcare Products, Inc. Spray composition with reduced dripping
ATE526973T1 (de) * 2001-06-18 2011-10-15 Noven Pharma Verbesserte arzneimittelabgabe in transdermalen systemen
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
DE602004025002D1 (de) * 2003-06-19 2010-02-25 Nicholas S Bodor Steigerung der aktivität und/oder der wirkungsdauer weicher steroide mit anti-entzündungswirkung für topische oder lokale verabreichung
DE602004008083T2 (de) * 2003-06-19 2008-04-24 Nicholas S. Gainsville Bodor Verstärkung der aktivität und/oder wirkdauer von ausgewählten entzündungshemmenden steroiden
US20050095205A1 (en) * 2003-10-31 2005-05-05 Ramesh Krishnamoorthy Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
KR20070004750A (ko) 2004-03-25 2007-01-09 보오슈 앤드 롬 인코포레이팃드 건안증 치료에 있어서의 로테프레드놀　에타보네이트의용도
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
US20070110812A1 (en) * 2005-11-14 2007-05-17 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
US7687484B2 (en) * 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
WO2013043387A1 (en) 2011-09-22 2013-03-28 Bausch & Lomb Incorporated Ophthalmic gel compositions
KR102665710B1 (ko) 2017-08-24 2024-05-14 노보 노르디스크 에이/에스 Glp-1 조성물 및 그 용도
IL294521A (en) 2020-02-18 2022-09-01 Novo Nordisk As glp-1 compounds and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
EP0709099A3 (en) * 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액

Also Published As

Publication number Publication date
AU5495298A (en) 1998-08-07
LT4677B (lt) 2000-07-25
YU36199A (sh) 2002-09-19
PT973501E (pt) 2004-02-27
ZA98303B (en) 1998-07-20
NO324619B1 (no) 2007-11-26
KR100471708B1 (ko) 2005-03-07
WO1998031343A2 (en) 1998-07-23
CZ294919B6 (cs) 2005-04-13
NZ509908A (en) 2004-12-24
ES2206880T3 (es) 2004-05-16
IL130979A0 (en) 2001-01-28
SK94899A3 (en) 2000-05-16
LT99100A (en) 2000-02-25
EA001775B1 (ru) 2001-08-27
CN1126535C (zh) 2003-11-05
NZ336990A (en) 2001-03-30
HUP0002473A2 (hu) 2000-12-28
TR199901663T2 (xx) 1999-09-21
EP0973501A2 (en) 2000-01-26
LV12449A (lv) 2000-04-20
PL334614A1 (en) 2000-03-13
HK1026138A1 (en) 2000-12-08
PL190753B1 (pl) 2006-01-31
CN1250370A (zh) 2000-04-12
ATE249205T1 (de) 2003-09-15
BR9806771A (pt) 2000-05-16
CZ237499A3 (cs) 2000-01-12
CA2278025C (en) 2005-09-06
WO1998031343A3 (en) 1998-09-17
AU730953B2 (en) 2001-03-22
DK0973501T3 (da) 2004-01-19
NO993453L (no) 1999-07-13
KR20000070214A (ko) 2000-11-25
HU226613B1 (en) 2009-04-28
LV12449B (en) 2000-09-20
UA52722C2 (uk) 2003-01-15
SI20057A (sl) 2000-04-30
HUP0002473A3 (en) 2001-01-29
SK283164B6 (sk) 2003-03-04
TW503113B (en) 2002-09-21
EP0973501B1 (en) 2003-09-10
AR011773A1 (es) 2000-09-13
EA199900659A1 (ru) 2000-02-28
ID21892A (id) 1999-08-05
DE69818026T2 (de) 2004-07-08
US6368616B1 (en) 2002-04-09
NO993453D0 (no) 1999-07-13
MXPA99006628A (es) 2005-01-10
AU730953C (en) 2002-02-07
CA2278025A1 (en) 1998-07-23
DE69818026D1 (de) 2003-10-16

Similar Documents

Publication Publication Date Title
RS49701B (sr) Vodene suspenzije za nazalnu primenu
IT1284049B1 (it) Medicamento per somministrazione nasale
ATE213142T1 (de) Nasaler dilatator
ATE302040T1 (de) Ringstent
DE69624405D1 (de) Nasenmaske
ITMI940326A0 (it) Derivati del 3,8-diazabiciclo[3.2.1.]lottano ad attivita' analgesica
DE69630396D1 (de) Physiologische mitralklappenbioprothese
DE69829008D1 (de) Nasen-, Mund- und Rachenraumkanüle
AU141695S (en) Respiratory mask
FR2771012B1 (fr) Pulverisateur nasal
RS49723B (sr) Farmaceutska kompozicija koja sadrži entakapon ili nitekapon kao i umreženi derivat celuloze
AU3290595A (en) An aqueous nasal suspension
AU6548598A (en) Enhancement of guar solution stability
BG102342A (en) Optical active derivative of phenylpyrimidine as an anlgesics
BG104825A (en) Ophthalmic solution comprising glycogen
DE59608611D1 (de) Topische aciclovir-zubereitung
TR199501104A2 (tr) Imidik asit türevleri.
MD1473F2 (en) Antiherpetic remedy
FR2728596B1 (fr) Degrilleur, notamment du type courbe
FI973631A (fi) 1,3-diolipohjaiset eetterit, menetelmä 1,3-diolipohjaisten eetterien valmistamiseksi sekä eetterien käyttö
DE59914598D1 (de) Coprozessiertes Polysaccharidprodukt mit unlöslicher Carboxymethylcellulose
AU125807S (en) Sleepmask
NO20002231D0 (no) Fysiologisk akseptable vandige løsninger
ES1032379Y (es) Mejora mediante recubrimiento del tampon higienico-sanitario.
ZA977042B (en) Nasal administration of agents for treatment of delayed onset emesis.